Cargando…

Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants

The current study aimed to investigate growth, safety and tolerance of partially hydrolysed infant formulae in healthy full-term infants. Fully formula-fed infants were randomised ≤14 days of age to receive a partially hydrolysed whey formula with 2.27 g protein/100 kcal (pHF2.27) or the same formul...

Descripción completa

Detalles Bibliográficos
Autores principales: Rigo, Jacques, Schoen, Stefanie, Verghote, Marc, van Overmeire, Bart, Marion, Wivinne, Abrahamse-Berkeveld, Marieke, Alliet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682927/
https://www.ncbi.nlm.nih.gov/pubmed/31331065
http://dx.doi.org/10.3390/nu11071654
_version_ 1783441978080362496
author Rigo, Jacques
Schoen, Stefanie
Verghote, Marc
van Overmeire, Bart
Marion, Wivinne
Abrahamse-Berkeveld, Marieke
Alliet, Philippe
author_facet Rigo, Jacques
Schoen, Stefanie
Verghote, Marc
van Overmeire, Bart
Marion, Wivinne
Abrahamse-Berkeveld, Marieke
Alliet, Philippe
author_sort Rigo, Jacques
collection PubMed
description The current study aimed to investigate growth, safety and tolerance of partially hydrolysed infant formulae in healthy full-term infants. Fully formula-fed infants were randomised ≤14 days of age to receive a partially hydrolysed whey formula with 2.27 g protein/100 kcal (pHF2.27) or the same formula with 1.8 g or 2.0 g protein/100 kcal (pHF1.8 and pHF2.0) until 4 months of age. The primary outcome was equivalence in daily weight gain within margins of ± 3 g/day; comparison with WHO Child Growth Standards; gastrointestinal tolerance parameters and number of (serious) adverse events were secondary outcomes. A total of 207 infants were randomised, and 61 (pHF1.8), 46 (pHF2.0) and 48 (pHF2.27) infants completed the study per protocol. Equivalence in daily weight gain was demonstrated for the comparison of pHF1.8 and pHF2.27, i.e., the estimated difference was −1.12 g/day (90% CI: [−2.72; 0.47]) but was inconclusive for the comparisons of pHF2.0 and pHF2.27 with a difference of −2.52 g/day (90% CI: [−4.23; −0.81]). All groups showed adequate infant growth in comparison with the World Health Organization (WHO) Child Growth Standards. To conclude, the evaluated partially hydrolysed formulae varying in protein content support adequate growth and are safe and well tolerated in healthy infants.
format Online
Article
Text
id pubmed-6682927
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66829272019-08-09 Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants Rigo, Jacques Schoen, Stefanie Verghote, Marc van Overmeire, Bart Marion, Wivinne Abrahamse-Berkeveld, Marieke Alliet, Philippe Nutrients Article The current study aimed to investigate growth, safety and tolerance of partially hydrolysed infant formulae in healthy full-term infants. Fully formula-fed infants were randomised ≤14 days of age to receive a partially hydrolysed whey formula with 2.27 g protein/100 kcal (pHF2.27) or the same formula with 1.8 g or 2.0 g protein/100 kcal (pHF1.8 and pHF2.0) until 4 months of age. The primary outcome was equivalence in daily weight gain within margins of ± 3 g/day; comparison with WHO Child Growth Standards; gastrointestinal tolerance parameters and number of (serious) adverse events were secondary outcomes. A total of 207 infants were randomised, and 61 (pHF1.8), 46 (pHF2.0) and 48 (pHF2.27) infants completed the study per protocol. Equivalence in daily weight gain was demonstrated for the comparison of pHF1.8 and pHF2.27, i.e., the estimated difference was −1.12 g/day (90% CI: [−2.72; 0.47]) but was inconclusive for the comparisons of pHF2.0 and pHF2.27 with a difference of −2.52 g/day (90% CI: [−4.23; −0.81]). All groups showed adequate infant growth in comparison with the World Health Organization (WHO) Child Growth Standards. To conclude, the evaluated partially hydrolysed formulae varying in protein content support adequate growth and are safe and well tolerated in healthy infants. MDPI 2019-07-19 /pmc/articles/PMC6682927/ /pubmed/31331065 http://dx.doi.org/10.3390/nu11071654 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rigo, Jacques
Schoen, Stefanie
Verghote, Marc
van Overmeire, Bart
Marion, Wivinne
Abrahamse-Berkeveld, Marieke
Alliet, Philippe
Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants
title Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants
title_full Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants
title_fullStr Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants
title_full_unstemmed Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants
title_short Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants
title_sort partially hydrolysed whey-based formulae with reduced protein content support adequate infant growth and are well tolerated: results of a randomised controlled trial in healthy term infants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682927/
https://www.ncbi.nlm.nih.gov/pubmed/31331065
http://dx.doi.org/10.3390/nu11071654
work_keys_str_mv AT rigojacques partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants
AT schoenstefanie partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants
AT verghotemarc partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants
AT vanovermeirebart partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants
AT marionwivinne partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants
AT abrahamseberkeveldmarieke partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants
AT allietphilippe partiallyhydrolysedwheybasedformulaewithreducedproteincontentsupportadequateinfantgrowthandarewelltoleratedresultsofarandomisedcontrolledtrialinhealthyterminfants